Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03359902 · ClinicalTrials.gov registry record · NA
Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03359902 is a NA study that has completed, run by University of Florida. The registered enrollment target is 59 participants.
The verdict
NCT03359902, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
Patients with amnestic mild cognitive impairment (MCI) often have compromised quality of life (QOL). Cognitive impairment is a major contributor to decrements in QOL and progression of MCI often leads to loss of independence and withdrawal from social participation. MCI, in many patients, is an early expression of neurodegenerative disease. Patients with MCI frequently convert to Alzheimer's disease (AD) (12-16 percent by some estimates per year). Treatments for MCI are of limited scope and availability and of limited effectiveness. Thus, there is great need for treatments that can improve cognition and extend QOL in patients with MCI. The investigators propose to investigate the effect of a non-invasive and safe intervention that should have direct influence on brain systems underlying AD, transcutaneous vagal nerve stimulation (tVNS).
Interventions
- DEVICE Sham stimulation
- DEVICE Transcutaneous vagal nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03359902
The ClinicalTrials.gov registry entry for NCT03359902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham stimulation is the first listed.
NCT03359902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03359902 about?
NCT03359902 is a clinical study titled "Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation". Patients with amnestic mild cognitive impairment (MCI) often have compromised quality of life (QOL). Cognitive impairment is a major contributor to decrements in QOL and progression of MCI often leads to loss of independence and withdrawal from social participation. MCI, in many patients, is an earl...
What is the current status of trial NCT03359902?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2018-01-01. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03359902?
The interventions under investigation include: Sham stimulation (DEVICE), Transcutaneous vagal nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT03359902?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.